| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |